Servier Polska Services sp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2002-03-12
Share capital
15,850,000.00 PLN
Activity description

Servier Polska Services is involved in the development and production of original pharmaceuticals, focusing on three therapeutic areas: cardiometabolism, oncology, and neurology. The company has received European Commission approval for worasydenib, a targeted molecular therapy for patients with glioma. Additionally, 98% of the active substances in Servier's original medications are manufactured within the European Union.

Registered address
ul. Burakowska 14, 01-066 Warszawa, Poland
Website
Opening hours
Mon–Fri, 8:30–17:30
Email
Phone
Social media
Electronic delivery address
AE:PL-96949-66492-GFGUS-17

Financials

Revenue history (in m)

Filing timeliness

Financial statements were filed on time, on average 40 days early. All were audited by a statutory auditor.

  • 202525/03/2026
  • 202414/04/2025
  • 202310/04/2024
  • 202213/04/2023
  • 202112/04/2022
  • 202021/12/2020
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Industry · Wholesale of pharmaceutical goods46 / 1,136
Top 4.0%
Division · Wholesale trade201 / 20,037
Top 1.0%
City · Warszawa405 / 56,729
Top <1%
Voivodeship · Mazowieckie513 / 76,892
Top <1%
Country · Poland1,427 / 297,069
Top <1%

Results vs industry

Revenue
This companyUSD 157.14mMedianUSD 1.08mAverageUSD 22.54m
Net profit
This companyUSD 2.96mMedianUSD 39.26kAverageUSD 885.01k
Operating costs
This companyUSD 152.62mMedianUSD 963.92kAverageUSD 21.21m
Assets
This companyUSD 52.42mMedianUSD 610.11kAverageUSD 11.92m

Industry

Websites

  • servier.plStrona główna – Servier Polska
    WordPress 6.7Yoast SEOApache

Public procurement

960 tenders recorded as contractor: 193 national ($6,888,530) and 767 EU ($115,102,483).

SubjectAmount
Supply of medicines and compounding accessories
$3,702
Supply of medicines and compounding accessories
$3,702
Successive supply of medicines to the hospital pharmacy
$156

Job offers

The company has its own careers page: servier.pl/dolacz-do-nas.

Authorized Representatives

Joanna Małgorzata Drewla age 60 – Management Board Member
Philippe Louis Malet – Management Board Member

Manner of representation

Each member of the management board has the right to represent the company individually.

Ownership

OwnerSharesShare valueStake
Arts Et Techniques Du Progres S.a.s.
15,050$4,065,370.0794.9527%
Others
800$216,099.415.0473%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2002-03-29.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Astrazeneca Pharma Poland sp. z o.o.
Janssen-Cilag Polska sp. z o.o.
Takeda Pharma sp. z o.o.
Biofarm sp. z o.o.
Zentiva Polska sp. z o.o.
Farmak International sp. z o.o.
Chiesi Poland sp. z o.o.
Synoptis Pharma sp. z o.o.
Polfarmex S.A.
Medac Gesellschaft Fur Klinische Spezialpraparate M.B.H. Branch (foreign co.)

Change history

DateEvent
2022-10-19Address change
2015-06-01Address change
2009-09-25Share capital increase
2005-01-10Share capital increase
2004-10-12Address change

FAQ

Last updated: 2026-03-25